| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Adjusted Operating EPS | $1.91 (+$0.23 YoY) | $3.04 (+$0.73 YoY) | +59% QoQ acceleration |
| Nuclear Capacity Factor | 94.8% | 96.8% | +200 bps operational excellence |
| Fewer Nuclear Outage Days | Not quantified | Both planned and unplanned vs prior year | Lower maintenance burden |
| PJM Capacity Revenue | First full month | Full quarter of higher PJM capacity revenues | Full quarterly recognition |
| ZEC Prices | Higher in both regions | Lower in both Midwest and New York vs Q3 2024 | Regional policy headwind |
| Commercial Sales Margins | Strong | Above long-term averages and above beginning of year expectations | Margin expansion acceleration |
| C&I Gas Renewal Rate | Strong | Quarter-over-quarter decline | One large, low-margin customer loss |
| Full Year EPS Guidance | $8.90 to $9.60 | $9.05 to $9.45 | Narrowed range, raised floor |
| Stock Compensation O&M | Normal | Creating O&M headwinds offsetting gross margin gains | New earnings drag from success |
| Nuclear Uprates Pipeline | 900 MW identified | 900 MW including 190 MW at Calvert Cliffs | No change in pipeline |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.